Get the full picture
Sign in to uncover key details.
AROG Pharmaceuticals
Manufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2700 W Plano Pkwy, Plano, Texas, 75075, ...Phone Number
(214) 593-0500Website
www.arogpharma.comRevenue
<$5 MillionIndustry
About AROG Pharmaceuticals
Arog Pharmaceuticals is focused on advancing Crenolanib, a Phase III-ready FLT3 inhibitor designed for post-allogeneic hematopoietic stem cell transplantation maintenance in high-risk acute myeloid leukemia (AML) patients. The company has successfully treated over 400 patients with this innovative therapy. Their primary clients include healthcare providers and institutions involved in the treatment of high-risk AML. Arog Pharmaceuticals aims to improve outcomes for patients facing this challenging condition.Explore more
AROG Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to AROG Pharmaceuticals
Compare insights from companies similar to AROG Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
AROG Pharmaceuticals Tech Stack
A closer look at the technologies used by AROG Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AROG Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Arog Pharmaceuticals is focused on advancing Crenolanib, a Phase III-ready FLT3 inhibitor designed for post-allogeneic hematopoietic stem cell transplantation maintenance in high-risk acute myeloid leukemia (AML) patients. The company has successfully treated over 400 patients with this innovative therapy. Their primary clients include healthcare p... Read More
